Literature DB >> 27154331

Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype.

Mya Myat Ngwe Tun1, Aung Kyaw Kyaw2, Nader Makki1, Rohitha Muthugala1, Takeshi Nabeshima1, Shingo Inoue1, Daisuke Hayasaka1, Meng Ling Moi1, Corazon C Buerano1, Saw Myat Thwe3, Kyaw Zin Thant3, Kouichi Morita4.   

Abstract

In 2013 in Myanmar, dengue epidemic occurred with 20,255 cases including 84 deaths. This study aimed to determine the serological and molecular characteristics of dengue virus (DENV) infection among children with clinical diagnosis of dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS) during this period. Single acute serum samples were collected from 300 children in Mandalay Children Hospital, Mandalay, Myanmar. Out of the 300 children, 175 (58.3%) and 183 (61%) were positive for anti-dengue IgM and anti-dengue IgG, respectively. Among the IgM positives, 41 (23.4%) had primary DENV infection. Thirty-nine DENV strains (23 DENV-1, 10 DENV-2 and 6 DENV-4) were successfully isolated after inoculation of the patient serum samples onto C6/36 cells. DENV 1 was the dominant serotype in the 2013 epidemic. There was no correlation between the infecting serotypes and clinical severities. The DENV-1 strains belonged to three lineages of the genotype 1; the DENV-2 strains were of the Asian I genotype and were separated into two lineages; and DENV-4 strains belonged to the same lineage of genotype I. It is of interest to note the diversity of DENV-1 and -2 circulating in the same location during June-August 2013. These DENV isolates were genetically close (98%-100%) to the other previously reported isolates from Myanmar and its neighboring countries, namely China, Thailand, Sri Lanka, Cambodia and Vietnam. Primary DENV infection was still high among the severe dengue cases. Different serotypes of DENV were co-circulating in 2013, however, genotype shift was not observed. Additionally, amino acid mutations were detected in the study strains not seen in the previously reported strains from other countries and Myanmar. This paper provided information on the circulating serotypes for the last 15years and the recent dengue situation in Mandalay, Myanmar after 2006.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dengue outbreak; Diversity; Myanmar; Phylogenetic analysis; Serology

Mesh:

Substances:

Year:  2016        PMID: 27154331     DOI: 10.1016/j.meegid.2016.04.025

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  12 in total

1.  Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015.

Authors:  A K Kyaw; M M Ngwe Tun; M L Moi; T Nabeshima; K T Soe; S M Thwe; A A Myint; K T T Maung; W Aung; D Hayasaka; C C Buerano; K Z Thant; K Morita
Journal:  Epidemiol Infect       Date:  2017-04-17       Impact factor: 4.434

2.  Secretory phospholipase A2 in the pathogenesis of acute dengue infection.

Authors:  Chandima Jeewandara; Laksiri Gomes; Sukhitha Udari; S A Paranavitane; N L A Shyamali; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  Immun Inflamm Dis       Date:  2016-12-11

Review 3.  A systematic review of the economic impact of rapid diagnostic tests for dengue.

Authors:  Jacqueline Kyungah Lim; Neal Alexander; Gian Luca Di Tanna
Journal:  BMC Health Serv Res       Date:  2017-12-29       Impact factor: 2.655

4.  Identification of novel antiviral of fungus-derived brefeldin A against dengue viruses.

Authors:  Muhareva Raekiansyah; Mihoko Mori; Kenichi Nonaka; Masanobu Agoh; Kazuro Shiomi; Atsuko Matsumoto; Kouichi Morita
Journal:  Trop Med Health       Date:  2017-10-26

5.  Complete genome analysis and characterization of neurotropic dengue virus 2 cosmopolitan genotype isolated from the cerebrospinal fluid of encephalitis patients.

Authors:  Mya Myat Ngwe Tun; Rohitha Muthugala; Takeshi Nabeshima; Aung Min Soe; Shyam Prakash Dumre; Lakmali Rajamanthri; Dulani Jayawardana; Shanthi Attanayake; Shingo Inoue; Kouichi Morita
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

6.  Epidemiological Characterization of the 2017 Dengue Outbreak in Zhejiang, China and Molecular Characterization of the Viruses.

Authors:  Hao Yan; Zheyuan Ding; Juying Yan; Wenwu Yao; Junhang Pan; Zhangnv Yang; Xiuyu Lou; Haiyan Mao; Junfen Lin; Jimin Sun; Juan Hou; Haocheng Wu; Chen Wu; Yanjun Zhang
Journal:  Front Cell Infect Microbiol       Date:  2018-07-04       Impact factor: 5.293

7.  Epidemiological and clinical characteristics of Dengue virus outbreaks in two regions of China, 2014 - 2015.

Authors:  Jiaqi Cao; Hong Deng; Lei Ye; Xuezheng Ma; Shuru Chen; Xiaohong Sun; Xuemin Wu; Tao Yan; Liping Zhang; Lijuan Liu; Lili Li; Wuping Li; Kongxin Hu
Journal:  PLoS One       Date:  2019-03-05       Impact factor: 3.240

8.  The evolutionary dynamics of DENV 4 genotype I over a 60-year period.

Authors:  Shaowei Sang; Jing Liu-Helmersson; Mikkel B M Quam; Hongning Zhou; Xiaofang Guo; Haixia Wu; Qiyong Liu
Journal:  PLoS Negl Trop Dis       Date:  2019-07-29

9.  Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019.

Authors:  Aung Min Soe; Mya Myat Ngwe Tun; Takeshi Nabeshima; Theingi Win Myat; Moh Moh Htun; Htin Lin; Nang Sarm Hom; Shingo Inoue; Khine Mya Nwe; Lynn Pa Pa Aye; Mizuki Fukuta; Kyaw Zin Thant; Futoshi Hasebe; Kouichi Morita; Sujan Shresta; Hlaing Myat Thu; Meng Ling Moi
Journal:  Viruses       Date:  2021-06-16       Impact factor: 5.048

10.  The burden of dengue, source reduction measures, and serotype patterns in Myanmar, 2011 to 2015-R2.

Authors:  Pwint Mon Oo; Khin Thet Wai; Anthony D Harries; Hemant Deepak Shewade; Tin Oo; Aung Thi; Zaw Lin
Journal:  Trop Med Health       Date:  2017-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.